$IQV

IQVIA Holdings Boosts FY26 Outlook; Shares Surge 10.6% - Update

IQVIA Holdings reported Q2 results and raised its FY2026 guidance. The company now expects adjusted earnings of $12.80 to $13.00 per share and revenue of $17.275 billion to $17.475 billion, citing stronger organic growth and updated M&A and FX impacts. Shares were up about 10.6% to $236.04 premarket.

Original reporting
Published Jul 28, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 1:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IQVIA Holdings Boosts FY26 Outlook; Shares Surge 10.6% - Update — source image
Decision brief

The 30-second read

$IQVBullishMed
01

Why it matters

The updated FY26 ranges provide a concrete basis to revise consensus estimates and valuation models, supporting continued trading volatility around the guidance.

02

Market read

A same-day guidance raise with specific numeric ranges is a direct catalyst for forward earnings expectations and near-term positioning.

03

What to watch

Traders will likely focus on whether the raised ranges reflect durable demand versus timing effects, and how much of the EPS uplift is attributable to non-organic items.

Relevance 8/10Novelty 7/10Timing: pre-market today, immediately after the Q2 results and FY26 guidance update

Background

IQV reported Q2 results and simultaneously updated its full-year 2026 adjusted earnings and revenue guidance ranges.

Company-level read

Ticker impact

$IQVBullishMedium confidence
Context

IQV raised FY26 adjusted EPS guidance to $12.80-$13.00 and revenue to $17.275B-$17.475B, citing stronger organic growth and M&A/FX impacts.

Expected impact

Near-term upside bias likely persists as traders reprice FY26 estimates, though follow-through depends on whether the raised ranges beat consensus.

Evidence & confidence

The article provides specific updated FY26 ranges and notes the company’s rationale (organic growth plus M&A/FX), which is actionable for forward-model adjustments.

Market effects

A guidance raise from a large life sciences services provider can modestly support sentiment for the broader CRO/life-sciences services complex.

Primarily US-listed sentiment impact via NYSE pre-market repricing.

Limited, unless peers interpret the organic growth strength as a broader demand signal.

Counterpoint

The guidance change may be partially driven by M&A and FX effects, so organic growth strength may be less bullish than the headline implies.

Key entities

  • IQVIA Holdings Inc.

    Raised FY26 adjusted EPS guidance to $12.80-$13.00 and revenue to $17.275B-$17.475B, citing stronger organic growth plus M&A and FX impacts.

Related articles

$IQVMed

5 Insightful Analyst Questions From IQVIA’s Q2 Earnings Call

IQVIA reported Q2 CY2026 results with revenue of $4.37B versus $4.30B estimates and adjusted EPS of $3.15 versus $3.03, with adjusted EBITDA of $994M. Management cited 6% organic growth and strong net new bookings. Full-year revenue guidance was lifted to $17.38B and adjusted EPS to $12.90. Analysts discussed bookings, outsourcing, AI, M&A, and margins.

Med

An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

IQVIA Holdings CEO sold about $26.1 million of stock appreciation rights with a Feb 2027 expiration, while retaining a large share position, according to the filing and article. The company reported Q2 revenue up 8.7% to $4.37B, adjusted EPS up 12.1% to $3.15, and record clinical bookings of $3.15B, raising full-year guidance to $17.475B.

MedAI 8/10

IQVIA Holdings Inc. Q2 2026 Earnings Call Summary

IQVIA reported Q2 2026 results and said organic revenue growth accelerated to 6% YoY, driven by improving market conditions and execution. Management raised full-year 2026 guidance, citing 100 bps higher organic growth and more M&A contribution. It expects flat adjusted EBITDA margins around 23.2% and noted Charles River asset acquisition added 50 bps to M&A growth.

$IQVMedAI 8/10

IQVIA Holdings (IQV) Soars on Revenue Growth Outlook, Strong Q2

IQVIA Holdings (NYSE:IQV) rose after reporting strong Q2 results and raising its full-year revenue growth outlook. Q2 revenue grew 8.7% to $4.37B, while attributable net income fell 3.7% to $256M. FY26 revenue guidance increased to $17.275B-$17.475B, with adjusted EBITDA $4.0B-$4.05B and buybacks of $2.819B authorized.

$IQVMedAI 8/10

IQVIA’s (NYSE:IQV) Q2 CY2026 Sales Top Estimates, Stock Soars

IQVIA (NYSE:IQV) reported Q2 CY2026 revenue of $4.37 billion, up 8.7% year on year and 1.5% above Wall Street estimates, according to the company. Full-year revenue guidance was $17.38 billion at the midpoint, 0.5% above estimates. Non-GAAP EPS was $3.15, 3.9% above consensus. The stock rose about 8.3% to $231 after results.